| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/13/2006 | EP1731154A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof |
| 12/13/2006 | EP1731153A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof |
| 12/13/2006 | EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof |
| 12/13/2006 | EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 12/13/2006 | EP1731144A1 Identification of genes altered in multiple myeloma |
| 12/13/2006 | EP1731131A1 Hgf production accelerator containing heparin-like oligosaccharide |
| 12/13/2006 | EP1730282A1 Glycosylation variants of ricin-like proteins |
| 12/13/2006 | EP1730196A2 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| 12/13/2006 | EP1730190A2 Inhibiting cav3 isoforms and the &25b splice varients for the diagnosis and treatment of cancer |
| 12/13/2006 | EP1730185A1 Cancer associated antigens |
| 12/13/2006 | EP1730138A1 Epothilone derivatives |
| 12/13/2006 | EP1730134A1 Pyridine inhibitors of erk2 and uses thereof |
| 12/13/2006 | EP1730111A2 Substituted bisarylurea derivatives as kinase inhibitors |
| 12/13/2006 | EP1730099A2 Mitotic kinesin inhibitors |
| 12/13/2006 | EP1729824A2 Phospholipid analogs for diagnosis and treatment of cancer |
| 12/13/2006 | EP1729817A1 Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 12/13/2006 | EP1729808A2 Combination therapy with azd2171 and 5-fu and/or cpt-11 |
| 12/13/2006 | EP1729807A2 Combination therapy |
| 12/13/2006 | EP1729803A2 Therapeutic use of anti-cs1 antibodies |
| 12/13/2006 | EP1729786A2 Administration of cisplatin by inhalation |
| 12/13/2006 | EP1729781A1 A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis |
| 12/13/2006 | EP1729776A1 Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists |
| 12/13/2006 | EP1729760A2 Use of beta-lapachone for the treatment of lung cancer |
| 12/13/2006 | EP1729756A2 Novel pharmaceutical compositions |
| 12/13/2006 | EP1729749A2 Use of renin inhibitors in therapy |
| 12/13/2006 | EP1729747A2 Thiol reactive agents as a therapeutic modality |
| 12/13/2006 | EP1664055B1 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 12/13/2006 | EP1613656B1 Cancerous disease modifying antibodies |
| 12/13/2006 | EP1551334A4 Medical device for intra-lumenal delivery of pharmaceutical agents |
| 12/13/2006 | EP1427424A4 Lpa receptor agonists and antagonists and methods of use |
| 12/13/2006 | EP1372737B8 Preparation for the prophylaxis of restenosis |
| 12/13/2006 | EP1268558B1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 12/13/2006 | EP1261712B1 Proteins named fctrx and nucleic acids encoding same |
| 12/13/2006 | EP1216042B1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 12/13/2006 | EP1143989B1 Exendins for glucagon suppression |
| 12/13/2006 | EP1126872B1 CANCER IMMUNOTHERAPY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 12/13/2006 | EP1123392B1 Prv-1 gene and the use thereof |
| 12/13/2006 | EP1121441B1 Selectively replicating viral vectors |
| 12/13/2006 | EP0927043B1 Compositions for gene transfer to the central nervous system |
| 12/13/2006 | EP0854885B1 Recombinant anti-cd4 antibodies for human therapy |
| 12/13/2006 | EP0809695B1 Transcription factor - e2f-5 |
| 12/13/2006 | CN1878779A 2'oxo-voruscharin and derivatives thereof |
| 12/13/2006 | CN1878775A Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents |
| 12/13/2006 | CN1878566A Multi-antigen vectors of melanoma |
| 12/13/2006 | CN1878555A Combination comprising n-(3-methoxy-5-methylpyrazin-2yl)-2-(4-[1,3,4-oxadiazol-2-y1]pyridine-3-sulphonamide and an lhrh analogue and/or bisphosphonate |
| 12/13/2006 | CN1878552A Methods of use of thrombin receptor antagonists |
| 12/13/2006 | CN1878547A Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 12/13/2006 | CN1878471A Hippophae rhamnoides compositions for cancer therapy |
| 12/13/2006 | CN1876684A A series of polypeptide capable of blocking IL-6 and its medicinal uses |
| 12/13/2006 | CN1876683A Human antibodies that bind human TNFalpha |
| 12/13/2006 | CN1876681A Cancer-suppressing protein and its gene and uses |
| 12/13/2006 | CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof |
| 12/13/2006 | CN1876676A Antineoplastic oligopeptide and its preparation method and application |
| 12/13/2006 | CN1876672A Steroid imidazole salt compound and its preparing process |
| 12/13/2006 | CN1876665A Method for refining oxaliplatin |
| 12/13/2006 | CN1876658A Gambogicacid derivative and its preparation method and uses in pharmacy |
| 12/13/2006 | CN1876657A Stabilization of macrolides |
| 12/13/2006 | CN1876650A N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses |
| 12/13/2006 | CN1876649A 1-(4- chloroanilino)-4-(4-methylpyridyl)-2,3-diazophenodiazine synthesis and uses |
| 12/13/2006 | CN1876186A Endostatin conjugate and its preparation method |
| 12/13/2006 | CN1876183A Methods and compositions for augmenting cancer chemotherapeutic agents |
| 12/13/2006 | CN1876177A Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
| 12/13/2006 | CN1876173A Thymus pentapeptide slow-release microshpere formulation for injection and its preparation method |
| 12/13/2006 | CN1876159A Preparation method for preparing traditional Chinese medicine for treating tumour, and the prepared traditional Chinese medicine |
| 12/13/2006 | CN1876158A Tujia nationality proved medicine recipe for treating cancer and tumour |
| 12/13/2006 | CN1876132A A medicine for treating malignant tumour |
| 12/13/2006 | CN1876070A A pharmaceutical composition for treating cancer, its preparation method and application |
| 12/13/2006 | CN1876016A Preparation method of compound kuhseng preparation for injection and medical use thereof |
| 12/13/2006 | CN1876010A Preparation method of estrogen activity-possessed red clover extractive and extractive thereof |
| 12/13/2006 | CN1875990A Pharmaceutical composition with anticancer activity |
| 12/13/2006 | CN1875984A A medicine for treating dermatosis, venereal diseases, cancer and AIDS and preparation method thereof |
| 12/13/2006 | CN1875980A Drop pills of vepeside and preparation process thereof |
| 12/13/2006 | CN1875978A Enteric-coated capsule of lentinan and preparation method thereof |
| 12/13/2006 | CN1875973A A pharmaceutical composition containing N3-o-toluyl-fluorouracil and its liposome preparation |
| 12/13/2006 | CN1875959A An anticancer pharmaceutical composition |
| 12/13/2006 | CN1875958A Pharmaceutical composition of scutellarin and baicalin with synergistic tumor resistance function |
| 12/13/2006 | CN1875946A Nanoparticle of 10-hydroxycamtothecine and preparation method thereof |
| 12/13/2006 | CN1875945A Lyophilized powder injection of cepharantine hydrochloride and preparation method thereof |
| 12/13/2006 | CN1875944A A carbowax modified stealthy liposome nanosphere of hydroxycamtothecine and preparation method thereof |
| 12/13/2006 | CN1875940A Anticancer sustained release agent containing clorfarabine and its synergist |
| 12/13/2006 | CN1875939A A sustained release anticancer agent carrying angiogenesis inhibitor and clorfarabine |
| 12/13/2006 | CN1875938A A sustained release anticancer injection containing clorfarabine and its synergist |
| 12/13/2006 | CN1875937A A sustained release injection carrying clorfarabine and cytotoxic drug |
| 12/13/2006 | CN1875936A Anticancer sustained release agent containing clorfarabine and cytotoxic drug |
| 12/13/2006 | CN1875935A A sustained release anticancer agent containing clorfarabine and cytotoxic drug |
| 12/13/2006 | CN1875934A An anticancer sustained release injection carrying clorfarabine and its synergist |
| 12/13/2006 | CN1875933A Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug |
| 12/13/2006 | CN1875932A A compound sustained release anticancer agent containing angiogenesis inhibitor |
| 12/13/2006 | CN1875931A An anticancer sustained release agent carrying angiogenesis inhibitor and cytotoxic drug |
| 12/13/2006 | CN1875930A An anticancer sustained release injection carrying tumor drug resistance reversal agent and cytotoxic drug simultaneously |
| 12/13/2006 | CN1289670C Polynucleotide useful for modulating cancer cell proliferation |
| 12/13/2006 | CN1289526C Stem cell factor |
| 12/13/2006 | CN1289524C Human telomerase active inhibitor protein and use thereof |
| 12/13/2006 | CN1289521C Anagonism peptide of tumor necrosis factor and its application |
| 12/13/2006 | CN1289506C Gambogic aid compound complex, its preparing method and medicinal composition containing the complex as active ingredient |
| 12/13/2006 | CN1289502C New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them |
| 12/13/2006 | CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 12/13/2006 | CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents |
| 12/13/2006 | CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1) |
| 12/13/2006 | CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |